Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1229, pseudogene (RNU6-1229P) is a processed pseudogene located on human chromosome 7 (cytogenetic band 7q11.21)[3]. As a member of the U6 small nuclear RNA pseudogene family, it originates from duplication and subsequent loss of function of a U6 snRNA gene. U6 snRNAs are essential non-coding RNAs involved in the spliceosome complex for pre-mRNA splicing, but pseudogenes like RNU6-1229P do not produce functional RNA molecules and lack known biological activity[2][3][11]. Pseudogenes may occasionally exert regulatory effects by acting as miRNA decoys or through other RNA-based mechanisms, but there is no evidence to date that RNU6-1229P has any such functional role[8][12]. This pseudogene is not a therapeutic target, not a known biomarker, and does not interact with drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1229, pseudogene (RNU6-1229P).